Cyclin D1 is a major target of miR-206 in cell differentiation and transformation

Cell Cycle

Volumn 12, Issue 24, 2013, Pages 3781-3790

  Alteri, Alessandra ^a   De Vito, Francesca ^a   Messina, Graziella ^b   Pompili, Monica ^a   Calconi, Attilio ^a   Visca, Paolo ^c   Mottolese, Marcella ^c   Presutti, Carlo ^a   Grossi, Milena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cell proliferation; Cell transformation; Cyclin D1; miR 206; Myogenic differentiation

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 206; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG TUMOR; MUSCLE DEVELOPMENT; MYOTUBE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; SKELETAL MUSCLE; TUMOR CELL;

CELL PROLIFERATION; CELL TRANSFORMATION; CYCLIN D1; MIR-206; MYOGENIC DIFFERENTIATION;

ADENOCARCINOMA; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN D1; HUMANS; LUNG NEOPLASMS; MICRORNAS; MUSCLE, SKELETAL; ORGAN SPECIFICITY;

EID: 84891843092     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26674     Document Type: Article

References (42)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-97; PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045- 5
2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-66; PMID:17060945; http://dx.doi.org/10.1038/nrc1997
3. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science 2005; 310:1288-9; PMID:16311325; http://dx.doi.org/10. 1126/science.1121566
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431:350-5; PMID:15372042; http://dx.doi.org/10.1038/nature02871
5. Townley-Tilson WH, Callis TE, Wang D. MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease. Int J Biochem Cell Biol 2010; 42:1252-5; PMID:20619221; http://dx.doi.org/10.1016/j. biocel.2009.03.002
6. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006; 174:677-87; PMID:16923828; http://dx.doi.org/10.1083/jcb.200603008
7. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 2006; 34:5863-71; PMID:17062625; http://dx.doi.org/10.1093/nar/gkl743
8. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 2006; 175:77-85; PMID:17030984; http://dx.doi.org/10.1083/jcb.200603039
9. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, Nicoletti C, Santini T, Sthandier O, Barberi L, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 2010; 12:341-51; PMID:20727829; http://dx.doi.org/10.1016/j.cmet.2010.07.008
10. Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang DZ. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 2010; 190:867-79; PMID:20819939; http://dx.doi.org/10.1083/jcb.200911036
11. Dey BK, Gagan J, Dutta A. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 2011; 31:203-14; PMID:21041476; http://dx.doi.org/10.1128/MCB.01009-10
12. Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 2012; 122:2054-65; PMID:22546853; http://dx.doi.org/10.1172/JCI62656
13. Hirai H, Verma M, Watanabe S, Tastad C, Asakura Y, Asakura A. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J Cell Biol 2010; 191:347-65; PMID:20956382; http://dx.doi.org/10.1083/ jcb.201006025
14. Goljanek-Whysall K, Pais H, Rathjen T, Sweetman D, Dalmay T, Münsterberg A. Regulation of multiple target genes by miR-1 and miR-206 is pivotal for C2C12 myoblast differentiation. J Cell Sci 2012; 125:3590-600; PMID:22595520; http://dx.doi.org/10.1242/jcs.101758
15. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T, Ponzetto C. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009; 119:2366-78; PMID:19620785
16. Yan D, Dong XdaE, Chen X, Wang L, Lu C, Wang J, Qu J, Tu L. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem 2009; 284:29596-604; PMID:19710019; http://dx.doi.org/10.1074/jbc.M109. 020511
17. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70; PMID:16103053; http://dx.doi.org/10.1158/0008-5472.CAN-05-1783
18. Adams BD, Furneaux H, White BA. The microribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007; 21:1132-47; PMID:17312270; http://dx.doi.org/10.1210/me.2007-0022
19. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 2008; 68:5004-8; PMID:18593897; http://dx.doi.org/10.1158/0008-5472.CAN-08- 0180
20. Chen X, Yan Q, Li S, Zhou L, Yang H, Yang Y, Liu X, Wan X. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett 2012; 314:41-53; PMID:21983130; http://dx.doi.org/ 10.1016/j.canlet.2011.09.014
21. Song G, Zhang Y, Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009; 284:31921-7; PMID:19723635; http://dx.doi.org/10.1074/jbc.M109.046862
22. Wang X, Ling C, Bai Y, Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec (Hoboken) 2011; 294:88-92; PMID:21157919; http://dx.doi.org/10.1002/ar.21287
23. Zhang T, Liu M, Wang C, Lin C, Sun Y, Jin D. Down-regulation of miR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 2011; 31:3859-63; PMID:22110210
24. Zhang L, Liu X, Jin H, Guo X, Xia L, Chen Z, Bai M, Liu J, Shang X, Wu K, et al. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett 2013; 332:94-101; PMID:23348698; http://dx.doi.org/10. 1016/j.canlet.2013.01.023
25. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10. 1038/ng1536
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-98; PMID:14697198; http://dx.doi.org/10.1016/S0092-8674(03)01018-3
27. Messina G, Blasi C, La Rocca SA, Pompili M, Calconi A, Grossi M. p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation. Mol Biol Cell 2005; 16:1469-80; PMID:15647380; http://dx.doi.org/10.1091/mbc.E04-07-0612
28. Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 1995; 15:3654-63; PMID:7791772
29. Hwang HW, Wentzel EA, Mendell JT. Cell-cell contact globally activates microRNA biogenesis. Proc Natl Acad Sci U S A 2009; 106:7016-21; PMID:19359480; http://dx.doi.org/10.1073/pnas.0811523106
30. Nohata N, Hanazawa T, Enokida H, Seki N. microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012; 3:9-21; PMID:22308266
31. McCarthy JJ. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta 2008; 1779:682-91; PMID:18381085; http://dx.doi.org/10.1016/j. bbagrm.2008.03.001
32. Tiainen M, Pajalunga D, Ferrantelli F, Soddu S, Salvatori G, Sacchi A, Crescenzi M. Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation. Cell Growth Differ 1996; 7:1039-50; PMID:8853900
33. Pajalunga D, Mazzola A, Salzano AM, Biferi MG, De Luca G, Crescenzi M. Critical requirement for cell cycle inhibitors in sustaining nonproliferative states. J Cell Biol 2007; 176:807-18; PMID:17353358; http://dx.doi.org/10.1083/ jcb.200608109
34. Pajalunga D, Puggioni EM, Mazzola A, Leva V, Montecucco A, Crescenzi M. DNA replication is intrinsically hindered in terminally differentiated myotubes. PLoS One 2010; 5:e11559; PMID:20644635; http://dx.doi.org/10.1371/journal.pone. 0011559
35. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73:1059-65; PMID:8513492; http://dx.doi.org/10.1016/0092-8674(93)90636-5
36. Beres BJ, George R, Lougher EJ, Barton M, Verrelli BC, McGlade CJ, Rawls JA, Wilson-Rawls J. Numb regulates Notch1, but not Notch3, during myogenesis. Mech Dev 2011; 128:247-57; PMID:21356309; http://dx.doi.org/10.1016/j.mod.2011. 02.002
37. Raimondi L, Ciarapica R, De Salvo M, Verginelli F, Gueguen M, Martini C, De Sio L, Cortese G, Locatelli M, Dang TP, et al. Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21(Cip1) expression and hampers tumour cell growth in vitro and in vivo. Cell Death Differ 2012; 19:871-81; PMID:22117196; http://dx.doi.org/10.1038/cdd.2011.171
38. Song G, Wang L. Nuclear receptor SHP activates miR-206 expression via a cascade dual inhibitory mechanism. PLoS One 2009; 4:e6880; PMID:19721712; http://dx.doi.org/10.1371/journal.pone.0006880
39. Singh A, Happel C, Manna SK, Acquaah-Mensah G, Carrerero J, Kumar S, Nasipuri P, Krausz KW, Wakabayashi N, Dewi R, et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest 2013; 123:2921-34; PMID:23921124; http://dx.doi.org/10.1172/JCI66353
40. Travaglione S, Messina G, Fabbri A, Falzano L, Giammarioli AM, Grossi M, Rufini S, Fiorentini C. Cytotoxic necrotizing factor 1 hinders skeletal muscle differentiation in vitro by perturbing the activation/deactivation balance of Rho GTPases. Cell Death Differ 2005; 12:78-86; PMID:15514676; http://dx.doi.org/10.1038/sj.cdd.4401522
41. Messina G, Biressi S, Monteverde S, Magli A, Cassano M, Perani L, Roncaglia E, Tagliafico E, Starnes L, Campbell CE, et al. Nfix regulates fetal-specific transcription in developing skeletal muscle. Cell 2010; 140:554-66; PMID:20178747; http://dx.doi.org/10.1016/j.cell.2010.01.027
42. Grossi M, La Rocca SA, Pierluigi G, Vannucchi S, Ruaro EM, Schneider C, Tatò F. Role of Gas1 downregulation in mitogenic stimulation of quiescent NIH3T3 cells by v-Src. Oncogene 1998; 17:1629-38; PMID:9796692; http://dx.doi.org/10.1038/sj.onc.1202090